Diosmin anti-tumour efficacious against Hepatocellular Carcinoma
Srinivasan Perumal, Langeswaran Kulanthaivel · Research Journal of Pharmacy and Technology · 2020
The present study absorbed the anti-cancer activity of diosmin at 50, 100, 150, 200 μM/ml for 24h of treatment on dose dependent manner. Group II animals were administrated 0.01% NDEA to induce primary liver carcinoma. Cancer bearing experimental animals were treated orally with the drug diosmin at the dosage level of 200 mg per kg/bodyweight for 28 successive days.